Jamie Surovik, MD
Dermatology · Centennial, CONPI 1699092221
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,565 of the $38,043 with a category attached, or 75.1%. Galderma Laboratories, L.p. accounts for 91.5% of it on its own, with 20 other manufacturers making up the rest. Among dermatology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $230.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$35K
- AbbVie$830
- Novartis$214
- Sanofi$211
- Dermavant Sciences, Inc.$196
- Pfizer$171
- plus $2K from 15 others
What the payments were for
- Consulting fees$2,3006%
- Speaking & faculty fees$28,56575%
- Travel & lodging$2,1426%
- Food & beverage$5,03613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 51 | $34,826 |
| AbbVie(2 entities) | 27 | $830 |
| Novartis | 10 | $214 |
| Sanofi | 6 | $211 |
| Dermavant Sciences, Inc. | 8 | $196 |
| Pfizer | 10 | $171 |
| Regeneron Healthcare Solutions, Inc. | 3 | $167 |
| Organon | 7 | $167 |
| E.r. Squibb & Sons, L.L.C. | 7 | $165 |
| Incyte Corporation | 4 | $156 |
| Sun Pharmaceutical Industries Inc. | 2 | $142 |
| LEO Pharma Inc. | 5 | $127 |
| Amgen | 1 | $122 |
| Lilly USA, LLC | 3 | $115 |
| Johnson & Johnson | 7 | $106 |
| UCB, Inc. | 4 | $78 |
| Strata Skin Sciences, Inc. | 1 | $77 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $74 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Journey Medical Corporation | 1 | $17 |
| DUSA Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,043 in reported general payments places this provider in the 90th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 11 | $74,729 |
| Dupixent PenDupilumab | 12 | $42,170 |
| Fluorouracil | 77 | $6,509 |
| Clobetasol Propionate | 55 | $3,060 |
| Metronidazole | 28 | $1,390 |
| Ketoconazole | 61 | $1,137 |
| Triamcinolone Acetonide | 101 | $985 |
| ValacyclovirValacyclovir Hcl | 24 | $964 |
| Clindamycin Phosphate | 11 | $528 |
| Fluocinonide | 11 | $445 |
| Doxycycline Hyclate | 21 | $444 |
| Minoxidil | 22 | $395 |
| Ciclopirox | 12 | $288 |
| Hydrocortisone | 47 | $288 |
| Hydroxyzine Hcl | 11 | $262 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Centennial
- Marcjonathan SerotaLittleton$3.2M
- Ammon LarsenLoveland$620K
- Victoria MossColorado Springs$473K
- Sheila BoyleWestminster$240K
- Mary Margaret KoberGlenwood Springs$202K
- Cathy KogerBoulder$182K
- Mona SadeghpourLone Tree$159K
- David NorrisAurora$156K
- Drew TaylorDenver$135K
- Dawnielle EndlyAurora$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.